FDA Approves First-of-its-Kind Intentional Genomic Alteration in Line of Domestic Pigs for Both Human Food, Potential Therapeutic Uses
The Pharma Data
DECEMBER 13, 2020
director of the FDA’s Center for Veterinary Medicine. The FDA also assessed the risk of the IGA to promote the emergence or selection of antimicrobial-resistant bacteria of human health concern in or on GalSafe pigs. Solomon , D.V.M., environment and determined it is no greater than from conventional pigs. In the U.S.,
Let's personalize your content